The SH2D2A gene encodes the T-cell-specific adapter protein (TSAd), which is involved in multiple signalling pathways, including those of the T-cell receptor, the vascular growth factor receptor 2 and the chemokine receptor CXCR4. SH2D2A is preferentially expressed in activated T cells, natural killer (NK) cells and endothelial cells. A major function of TSAd seems to be to modulate Src kinase activity within the cell. The SH2D2A gene as well as its gene region have been implicated in genetic susceptibility to autoimmune disease in both humans and mice. In this article, the current status of knowledge of the SH2D2A gene and its implications for our future understanding of multiple sclerosis are discussed.
The SH2D2A gene encodes a cytoplasmic adapter protein, T-cell-specific adapter protein (TSAd), which is expressed in activated T cells as well as in endothelial cells. Several lines of evidence imply a contribution of this gene to susceptibility to the development of multiple sclerosis (MS). In this article we will review current evidence, and point to some important aspects of the function of this gene for our future understanding of MS.
Most Susceptibility Genes in Multiple Sclerosis Contribute with Small Effects
Much effort is currently being put into the identification of susceptibility genes in autoimmune diseases such as MS. These diseases are 'complex' in the sense that many genes as well as environmental factors contribute to the development of disease. Until recently, only genes in the human leukocyte antigen (HLA) class II region had clearly been shown to contribute to the genetic susceptibility of MS, 1 with an odds ratio (OR) of about 2.0. 2 The failure to identify other gene regions harbouring MS-predisposing genes by genome-wide linkage studies in families from various MS populations 3 suggests that the other genes predisposing to MS contribute with only small or moderate effects. Still, suggestive linkage to particular gene regions in MS families has allowed identification of new MS-susceptibility gene candidates. One such gene is the MHC2TA gene, which encodes a transcription factor that regulates levels of major histocompatibility complex (MHC) class II expression and that has been found to be associated with MS in humans as well as experimental autoimmune encephalomyelitis (EAE) in the rat. 4 Another example is the protein kinase C alpha gene (PRKCA). 5, 6 The associated polymorphism in this gene correlates with altered expression levels of PKRCA in monocytes. 6 In line with the notion that MS-susceptibility genes contribute with small effects, high-density genome-wide association studies (GWAS) of large patient materials allow identification of novel susceptibility genes contributing small increases to the risk of developing MS. 7 Two of these are IL7R and IL2RA, which have now been replicated in several independent studies. [8] [9] [10] Although the effect of single genes is only to confer small increases in genetic susceptibility, a combination of two genes may act synergistically and amplify the genetic effect considerably. Figure 1) . 12 Recently, it has been recognised that antigen-specific T-regulatory (T reg ) cells confer resistance to organspecific autoimmunity, and the role of these cells in limiting autoimmune tissue damage has been documented in many disease models, including MS. 13 Activation of T cells is thus a double-edged sword that needs to be tightly regulated.
Genes Controlling T-cell Activation Are Candidate Genes in Autoimmune Disease
It is very likely that HLA molecules confer susceptibility to MS and other autoimmune diseases through presentation of particular diseasepromoting peptides to T cells. The sequence of events depicted in The SH2D2A Gene -Contributions to Our Future Understanding of Multiple Sclerosis the development of MS. This is exemplified by mice that have altered susceptibility to spontaneous or induced experimental autoimmune diseases due to dysregulation of the T-cell activation process , 14, 15 chemokine-regulated cellular migration, 16, 17 or altered blood-brain barrier function. 18 In the search for novel candidate genes in MS that are expressed in activated T-cells, we previously identified and cloned the TSAd encoded by the SH2D2A gene.
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The SH2D2A Gene Is Located in a Chromosomal Region Regulating Experimental Demyelinating Disease
The SH2D2A gene in the mouse is located within Eae3, a chromosomal region that has been implicated in genetic susceptibility to EAE in the mouse. 20, 21 Eae3 harbours multiple genes of immunological relevance, including SH2D2A. However, as yet the susceptibility gene within Eae3
has not yet been identified.
Polymorphisms in the SH2D2A Gene
There are several potentially functionally relevant polymorphisms within the SH2D2A gene. In the SH2D2A promoter, there is a highly polymorphic dinucleotide (GA) repeat located -345 basepairs (bp) upstream of the first coding ATG. 22 Genotypes homozygous for short alleles of this GA repeat appear to be associated with reduced expression of TSAd in activated primary CD4 + T cells. 23 In shown that phosphorylation of a serine N-terminal to an SH2 domain may influence the specificity of the SH2 domain for its tyrosine phosphorylated ligands. 24 An intriguing possibility is thus that the S52N polymorphism might affect the function of TSAd through modulation of its SH2 domain specificity.
SH2D2A Is Associated with Multiple Sclerosis
Initially, the GA repeat polymorphism in the human SH2D2A gene promoter was found to be associated with MS 23 43 and transforming growth factor beta receptor (TGFβR) 44 (see Figure 2 ). 
A potentially auto-aggressive T cell is activated by presentation of antigen on a professional antigen presenting cell (APC) in the lymph node (1). The activated T cell migrates into the bloodstream (2) and may cross the blood-brain barrier into the brain (3). In the target tissue the T cell may eventually re-encounter the initial or a very similar peptide-human leukocyte antigen (HLA) complex presented by microglia and thus become re-activated to proliferate and secrete potentially harmful cytokines (4). aT = activated T-cell; CNS = central nervous system; TCR = T-cell receptor.
cell, without the risk that Lck simultaneously phosphorylates bystander proteins in their vicinity. The SH2 domain of TSAd could provide the necessary localisation information for the TSAd-Lck complex. However, as yet only VEGFR-2 and valocin-containing protein (VCP) are known to bind to the TSAd SH2 domain. 32, 39 It is highly likely that additional targets for the TSAd SH2 domain exist within T cells that may point to the more precise role of TSAd in temporarily controlling Lck activity, but these remain to be determined. Recently, TSAd was also found to be involved in signalling from G-protein coupled receptors (GPCR) 48 
Epistatic Interaction Between Susceptibility Genes in Multiple Sclerosis and Possibility of Novel Immune Therapies
The association of SH2D2A with MS is an example among many, most of which are probably yet to be determined, where a gene provides a moderate increase in risk of disease susceptibility. The mechanism by which these genes contribute to disease may be manifold, and it may be very difficult to pinpoint the exact mode of disease promotion. with particular alleles of less effect within or outside of the HLA complex may yield a considerable increase in disease risk, 49 or decrease the severity of the (experimental) disease.
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Conclusion
In conclusion, identification of susceptibility genes will have low power in identifying people at risk of developing MS. However, their identification, the characterisation of their function and their possible interactions with other susceptibility genes will point to pathways that are putative targets for novel immune therapies in MS. n 
